2013--2017 China's intravenous human immunoglobulin (pH4 market research and investment strategy ..

2013--2017 China's intravenous human immunoglobulin (pH4) market research and investment strategy research report ----------------------------- --------------------------------------- 〖Report No. 68251〗 〖〗 2013 release date July 〖delivery〗 EMIL electronic version or EMS reporting format〗 〖〗 〖paper version: 6500 yuan〗 〖electronic version: 6800 yuan 〖paper + electronic]: 7000 yuan (price discount)〗 〖Order Phone 010 〗 〖QQ 1271943744 -56,205,768 Customer Service, 24 hours: 18,211,180,815 〖Contact〗 〖Zhao Yingying source connected〗 http://www.hjwxyjy.com/yiyaobaojian/qita/68251.html (click see text) ------ --------------------------------- [Report Contents] Chapter One intravenous human immunoglobulin (pH4) Industry Overview 1 1.2 classification, use, works a chain structure 4 1.3 1.4 1.4.1 Market Situation and Trend 8 8 1.4.2 Development Status 1 1.1 Definitions domestic industry competition 10 1.4.3 Market Prospects 12 1.5 Policy Analysis 13 Chapter Chapter II intravenous human immunoglobulin (pH4) production technology and cost analysis 22 2.1 Technical Data 22 2.2 Analysis of Manufacturing Technology Cost Structure Analysis 24 2.3 26 2.4 27 2.5 Description of material and equipment technology trends and difficulties intravenous Chapter 27 human immunoglobulin (pH4) production, supply and market status and forecast analysis needs 28 3.1 intravenous human immunoglobulin (pH4) production and supply 28 3.2 Summary of intravenous human immunoglobulin (pH4) in different areas (广东 贵州 Shanghai, Sichuan and Shandong Henan) Production Summary 33 3.3 intravenous human immunoglobulin (pH4) capacity utilization of 37 3.4 intravenous human immunoglobulin (pH4) demand 39 3.5 Summary of intravenous human immunoglobulin (pH4) domestic supply and demand 40 3.6 Static NOTE human immunoglobulin (pH4) cost, price, production value, profit margins 41 3.7 List of intravenous human immunoglobulin (pH4) import export consumption volume statistics 41 Chapter IV intravenous human immunoglobulin (pH4) domestic core The Shanghai Business Research 42 4.1 44 4.2 Hualan (002007), Shandong Taibang 49 4.3 53 4.4 57 4.5 Shanxi Chengdu Rongsheng Herbalife Shanghai RAAS 00,225,266 63 4.6 4.7 Guizhou Taibang Biological (Guizhou peak) 71 4.8 Shenzhen Wei Wu Guangming 77 4.9 82 4.10 Zhengzhou go the same way biological state and Sichuan Yuanda Shuyang 87 4.11 90 4.12 94 4.13 Boya Guangdong Shuanglin Biological 30,029,498 4.14 4.15 103 in Wuhan the Si Feike send Harbin (Harbin SEQUEL) 108 4.16 113 4.17 Shanghai emerging pharmaceutical Wuhan Zhongyuan Reid Guangdong Wei-lun 123 118 4.18 4.19 Green Cross (China) 126 4.20 130 4.21 Lanzhou Guizhou Thai Xi'an back to the days of the 132 4.22 135 4.23 Hunan ancient Han purple (000,590) Southern Mountain Pharmaceuticals 143 4.26 139 4.25 Zhejiang Kang Watson bio 300142 (Hebei Daan) 147 Chapter intravenous human immunoglobulin (pH4) project investment feasibility analysis 149 5.1 intravenous human immunoglobulin (pH4) project SWOT analysis 149 52 200 bottles / year intravenous human immunoglobulin ( pH4) (Specifications: 2.5g) project feasibility analysis 151 5.2.1 Project Name 5.2.2 product and the proposed scale of 151 151 151 5.2.4 5.2.3 Main Construction Content duration of the project planning contents 152 151 5.2.5 Investment Section chapters intravenous human immunoglobulin (pH4) industry study concluded 153 [Charts] FIG intravenous human immunoglobulin (pH4) physical map 1 Table intravenous human immunoglobulin (pH4) Specification (eight kinds) some provinces 2 temporary maximum retail price list in 2012 in Shandong Province on the adjustment of intravenous human immunoglobulin (ph4) hanging price 2 Figure 4 Figure blood products industry chain intravenous human immunoglobulin (pH4) chain 5 Table blood products industry business model and business processes 7 Table blood products raw material procurement, research and development, production, quality inspection and product sales system 8 Figure 2005--2011 China's blood products industry sales revenue (million) Change and growth 10 Figure 2002-2012 National Investment pulp (tonnes) and the growth rate of 10 Figure of blood plasma products, the geographical distribution station of the end of 2012 10 Figure principal amount of blood plasma products business stand comparison 11 Table of mainstream health insurance coverage of blood products blood products industry Table 12 Figure 16 Table intravenous regulatory system List of relevant policies and human immunoglobulin 20 form the Shanghai Price Bureau in February 2010 raised the maximum retail price of static prop 21 Figure intravenous human immunoglobulin (pH4) and other major blood products production process Figure 23 Figure intravenous human immunoglobulin (pH4) production cycle for 7-8 months 24 Blood flow diagram single plasma separation process blood products 24 Figure 25 showing static injection of human immunoglobulin (IVIG) production technology 25 Figure intravenous human immunoglobulin (pH4) production cost structure 26 Table intravenous human immunoglobulin (pH4) production line equipment 27 Table 2013--2017, China 25 manufacturers of intravenous human immunoglobulin (pH4) (2.5g / bottle) production capacity and total capacity (million bottles) List of 28 Table 2013--2017, China 25 manufacturers of intravenous human immunoglobulin (pH4) capacity share a list of 29 Figure 2012 China 25 manufacturers of intravenous human immunoglobulin (pH4) capacity share of 30 table 2013--2017, China 25 Manufacturers of intravenous human immunoglobulin (pH4) (2.5g / bottle) yield and production (million bottles) List 30 Table 2013--2017, China 25 manufacturers of intravenous human immunoglobulin (pH4) production share list 31 Figure 2012 China 25 manufacturers of intravenous human immunoglobulin (pH4) production share 32 Table basic situation the country's main blood products enterprises Table 33 Table 2013--2017 Different regions of China (Sichuan, Henan and Shanghai Guangdong, Shandong and Guizhou and other provinces) List 33 Table 2013 intravenous human immunoglobulin (pH4) production capacity and total capacity (million bottles) - in different regions of China (Sichuan, Henan and Shanghai Guangdong, Shandong and Guizhou and other provinces) share a list of intravenous human immunoglobulin (pH4) capacity market in 2017 34 Figure 2012 in different regions of China (Sichuan, Henan and Shanghai Guangdong, Shandong and Guizhou and other provinces) intravenous human immunoglobulin (pH4) capacity market share Figure 35 Table 2013--2017 Different regions of China (Sichuan, Henan and Shanghai Guangdong, Shandong and Guizhou and other provinces) Static NOTE human immunoglobulin (pH4) yield and production (million bottles) List 35 Table 2013--2017 Different regions of China (Sichuan, Henan and Shanghai Guangdong, Shandong and Guizhou and other provinces) intravenous human immunoglobulin (pH4) production market share List of 36 Figure 2012 in different parts of China (Sichuan, Henan and Shanghai Guangdong, Shandong and Guizhou and other provinces) intravenous human immunoglobulin (pH4) production market share Figure 37 Figure 2013--2017 China's intravenous human immunoglobulin (pH4) Capacity Production (million bottles ) and growth rate 37 Table 2013--2017 China's intravenous human immunoglobulin (pH4) Production Capacity Utilization List 37 Table 2012 China intravenous human immunoglobulin (pH4) Production Capacity Utilization Figure 38 List of blood products administered pulp rise in the amount of U-shaped track 39 Figure blood products administered plasma volume and demand situation and developed countries 39 Table of intravenous human immunoglobulin (pH4) consumption level of 40 comparative table 2013--2017 China's intravenous human immunoglobulin (pH4) total demand (million bottles) List 40 Table 2013--2017 China's intravenous human immunoglobulin (pH4) supply demand gap volume (million bottles) List 40 Table 2013--2017 China's intravenous human immunoglobulin (pH4) production (million bottles) price cost profit (yuan / bottle) value (million) and profit margin 41 Table 2013 - China intravenous human immunoglobulin (pH4) State Production Exports Imports Consumption in 2017 (ten thousand bottle) List of 41 major manufacturers of blood products table list of 42 cases of blood products manufacturer in Figure nationwide distribution pulp station 44 meter Shanghai Institute of Biological Products Co., Ltd. Company Information Table (Products Design, product areas, origin, production, expansion planning, market position, contact information, etc. 13 items) 44 Figure Shanghai Institute of Biological Products Co., Ltd. intravenous human immunoglobulin (pH4) 46 Table Shanghai Institute of Biological Products Co., Ltd. intravenous human immunoglobulin (pH4) Technical Data 46 Table 2013--2017 the Shanghai Institute of Biological Products Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million) profit information table 48 Figure 2013--2017 in Shanghai Institute of Biological Products Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 48 Table Hualan Biological Engineering Co., Ltd. Company Information Table (Products Design, product areas , origin, production, expansion plans, market position, contact information, etc. 13 items) 49 Figure 2009--2014 Love Portland biological plasma collection volume (tonnes) forecast 50 Figure Hualan Biological Engineering Co., Ltd. intravenous human immunoglobulin ( pH4) 50 Table Hualan Biological Engineering Co., intravenous human immunoglobulin (pH4) Technical Data 50 Table 2013--2017 Love Lan Biological Engineering Co., intravenous human immunoglobulin (pH4) Capacity Production (million bottles) Maori cost price (yuan / bottle) value (million) profit information table 52 in FIG 2013--2017 Love Lan Biological Engineering Co., intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 53 Table Shandong Taibang Biological Products Co., Ltd. Company Information Table (Products Design, product areas, origin, production, expansion plans, market position, contact information, etc. 13 items) 53 Figure Shandong Taibang intravenous human immunoglobulin (pH4) 55 Table Shandong Taibang intravenous human immunoglobulin (pH4) Technical Data 55 Table 2013--2017 Shandong Taibang Biological Products Co., intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin (yuan / bottle) value ( million) profit information table 56 in FIG 2013--2017 Shandong Taibang Biological Products Co., intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 57 Table Chengdu Rongsheng Pharmaceutical Co., Ltd. Company Information Table ( Product Design, product areas, origin, production, expansion plans, market position, contact information, etc. 13 items) 57 Figure Chengdu Rongsheng intravenous human immunoglobulin (pH4) 59 Figure Chengdu Rongsheng lyophilized intravenous human immunoglobulin globulin (pH4) 59 Table Chengdu Rongsheng intravenous human immunoglobulin (pH4) Technical Data 60 Table Chengdu Rongsheng lyophilized intravenous human immunoglobulin (pH4) Technical Data 61 Table 2013--2017 Chengdu Rongsheng Pharmaceutical Co., intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million) profit information table 62 in FIG 2013--2017 Chengdu Rongsheng Pharmaceutical Co., Ltd. Jing NOTE human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 62 Table Shanxi Herbalife Biological Products Co., Ltd. Company Information Table (Products Design, product areas, origin, production, expansion plans, market position, contact information contents 13) 63 Figure Herbalife Biological Products Co., Ltd. Shanxi intravenous human immunoglobulin (pH4) 64 Table Herbalife Biological Products Co., Ltd. Shanxi intravenous human immunoglobulin (pH4) Technical Data 64 Table 2013 --2017 Herbalife Biological Products Co., Ltd. Shanxi intravenous human immunoglobulin (pH4) (Size: 10g) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million) profit information table 65 in Fig. 2013--2017 Herbalife Biological Products Co., Ltd. Shanxi intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and a growth rate 66 Table Shanghai RAAS Blood Products Co., Ltd. Company Information Table (Products Design, product areas , origin, production, expansion plans, market position, contact information, etc. 13 items) 67 Figure 2007--2015 年 Shanghai RAAS 68 plasma collection Forecast Figure RAAS Blood Products intravenous human immunoglobulin (pH4) 68 Table Shanghai RAAS Blood Products intravenous human immunoglobulin (pH4) Technical Data 68 Table 2013 - Shanghai RAAS Blood Products Co., intravenous human immunoglobulin (pH4) Capacity Production (million bottles) in 2017 gross profit on cost price ( yuan / bottle) value (million) profit information table 70 in FIG 2013--2017 年 Shanghai RAAS Blood Products Co., intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 71 Table Guizhou Taibang Biological Co., Ltd. Company Information Table (Products Design, product areas, origin, production, expansion plans, market position, contact information, etc. 13 items) 72 Figure Guizhou Taibang intravenous human immunoglobulin (pH4) 73 Table Guizhou Taibang quiet NOTE human immunoglobulin (pH4) Technical Data 74 Table 2013--2017 Guizhou Taibang Biological Products Co., Ltd. (formerly Guizhou peak) intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price Gross profit (yuan / vial) output value (million) profit information table 76 in FIG 2013--2017 Guizhou Taibang Biological Products Co., Ltd. (formerly Guizhou peak) intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate of 77 Table Shenzhen Wei Wu Guangming Biological Products Co., Ltd. Company Information Table (Products Design, product areas, origin, production, expansion plans, market position, contact information, etc. 13 items) 77 Figure Shenzhen Wei Wu Guangming Biological Products Co., Ltd. lyophilized intravenous human immunoglobulin (pH4) 79 Table Shenzhen Wei Wu Guangming Biological Products Co. lyophilized intravenous human immunoglobulin (pH4) Technical Data 79 Table 2013--2017 Shenzhen City Wei Wu Guangming Biological Products Co. Company intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million) profit information table 81 shown 2013--2017 Shenzhen City Wei Wu Guangming Biological Products Co., intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 81 Table go the same way Biopharmaceutical Co., Ltd. Company Information Table (Products Design, product areas, origin, production, expansion plans, market position, contact information, etc. 13 content) 82 Figure go the same way biological lyophilized intravenous human immunoglobulin (PH4) 83 Table go the same way biological lyophilized intravenous human immunoglobulin (PH4) Product Specifications 83 Table 2013--2017 年 biopharmaceutical shares go the same way Limited intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million) profit information table 86 in FIG 2013--2017 年 Biological Pharmaceutical Co., Ltd. intravenous people go the same way Immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 87 Table State Pharmaceutical Co., Ltd. Company Information Table (Products Design, product areas, origin, production, expansion plans, market position, contact information, etc. 13 Content) Pharmaceutical Co., Ltd. 87 Figure state and intravenous human immunoglobulin (pH4) 88 Table Pradesh and Pharmaceutical Co., intravenous human immunoglobulin (pH4) Technical Data 88 Table 2013--2017 年 state and Pharmaceutical Co. shares Company intravenous human immunoglobulin (pH4) production (million bottles) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million) profit information table 89 in FIG 2013--2017 年 State Pharmaceutical Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 89 Table Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information Table (Products Design, product areas, origin, production, expansion plans, market position , contact information, etc. 13 items) 90 Figure Shuyang Pharmaceutical intravenous human immunoglobulin (pH4) 91 Table Shuyang Pharmaceutical intravenous human immunoglobulin (pH4) Technical Data 92 Table 2013--2017 Sichuan Yuanda Shuyang Yang Pharmaceutical Co., intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million) profit information table 93 in FIG 2013--2017 Sichuan Yuanda Shuyang Pharmaceutical Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 93 Table Guangdong Shuanglin Biological Pharmaceutical Co., Ltd. Company Information Table (Products Design, product areas, origin, production, expansion plans, market status, contact information, etc. 13 items) 94 Figure Guangdong shuanglin intravenous human immunoglobulin (pH4) 95 Table Guangdong shuanglin intravenous human immunoglobulin (pH4) Technical Data 95 Table 2013--2017 Guangdong Shuanglin Biological Pharmaceutical Co., intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million) profit information table 97 in FIG 2013--2017 Guangdong Shuanglin Biological Pharmaceutical Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 98 Table Jiangxi Boya Biological Pharmaceutical Co., Ltd. Company Information Table (Products Design, product areas, origin, production, expansion plans, market position, contact information, etc. 13 content) 98 Figure Jiangxi Boya Biological Pharmaceutical Co., Ltd. of intravenous human immunoglobulin (pH4) 100 Table Jiangxi Boya Biological Pharmaceutical Co., Ltd. of intravenous human immunoglobulin (pH4) Technical Data 100 Figure 2009-2013 In Boya Biological vote pulp (tonnes) forecast 102 Table 2013--2017 Jiangxi Boya Biological Pharmaceutical Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million ) margin information table 102 in FIG 2013--2017 Jiangxi Boya Biological Pharmaceutical Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 103 Table Wuhan Institute of Biological Products Co., Ltd. Company Information Table ( Product Design, product areas, origin, production, expansion plans, market position, contact information, etc. 13 items) 103 Figure Wuhan Institute of Biological Products Co., Ltd. intravenous human immunoglobulin (pH4) 105 Table Wuhan Biological Products The limited liability company intravenous human immunoglobulin (pH4) Technical Data 105 Table 2013--2017 Wuhan Institute of Biological Products Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price gross profit (yuan / vial) output value (million) profit information table 107 in FIG 2013--2017 Wuhan Institute of Biological Products Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 107 Table Harbin send Bakersfield Branch of the Pharmaceutical Co., Ltd. Company Information Table (Products Design, product areas, origin, production, expansion plans, market position, contact information, etc. 13 items) 108 Figure Biological Pharmaceutical Co., Ltd. Harbin faction Si Feike intravenous person Immunoglobulin (pH4) 109 Figure Biological Pharmaceutical Co., Ltd. Harbin faction Si Feike lyophilized intravenous human immunoglobulin (pH4) 110 Table Biological Pharmaceutical Co., Ltd. Harbin faction Si Feike intravenous human immunoglobulin (pH4) Technical Data 111 Table 2013--2017 Harbin Pharmaceutical Co., sent Si Feike biological intravenous human immunoglobulin (pH4)) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million) profit Emerging growth 112 Table Shanghai Pharmaceutical Co., Ltd. Company Information Table 2017 Biological Pharmaceutical Co., Ltd. Harbin send 斯菲科 intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and (product specification - Information List 112 Figure 2013 type of product areas, origin, production, expansion plans, market position, contact information, etc. 13 items) 113 Figure Shanghai Pharmaceutical Co., Ltd. Emerging intravenous human immunoglobulin (pH4) 114 Table Shanghai Pharmaceutical Co., Ltd. Emerging intravenous human immunoglobulin (pH4) Technical Data 114 Figure Shanghai Pharmaceutical Co., Ltd. Emerging lyophilized intravenous human immunoglobulin (pH4) 116 Table Shanghai Pharmaceutical Co., Ltd. Emerging lyophilized intravenous human immunoglobulin (pH4) Product Technology Parameters 116 Table 2013--2017 Emerging Pharmaceutical Co., Ltd. in Shanghai intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million) profit information table 117 Figure 2013-2017 Emerging Pharmaceutical Co., Ltd. in Shanghai intravenous human immunoglobulin (pH4) capacity production and growth rate 118 Table Wuhan Zhongyuan Company Information Table Reid Biological Products Co., Ltd. (product specification type, product areas, origin, production capacity, expansion plans , market position, contact information, etc. 13 items) 118 Figure Wuhan Zhongyuan Ruide Biological Products Co., Ltd. intravenous human immunoglobulin (pH4) 120 Table Wuhan Zhongyuan Ruide Biological Products Co., Ltd. intravenous human immunoglobulin (pH4 ) Technical Data 120 Table 2013--2017 Reid Wuhan Zhongyuan Biological Products Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million) profit information List 121 Figure 2013--2017 Reid Wuhan Zhongyuan Biological Products Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 122 Table Guangdong Wei-lun Biological Pharmaceutical Co., Ltd. Company Information Table (Products Specifications Type , product areas, origin, production, expansion plans, market position, contact information, etc. 13 items) 123 Figure Guangdong Wei-lun lyophilized intravenous human immunoglobulin (pH4) 124 Table Guangdong Wei-lun lyophilized intravenous human immunoglobulin protein (pH4) Technical Data 124 Table 2013--2017 Guangdong Wei-lun Biological Pharmaceutical Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million) profit growth rate 126 Table Green Cross (China) Biotechnology Co., Ltd. Company Information Table 2017 Guangdong Wei-lun Biological Pharmaceutical Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and (product specification - Information List 125 Figure 2013 type of product areas, origin, production, expansion plans, market position, contact information, etc. 13 items) 126 Figure Green Cross (China) Biotechnology Co., Ltd. intravenous human immunoglobulin (pH4) 127 Table Green Cross (China) Biological Products Co., intravenous human immunoglobulin (pH4) Technical Data 128 Table 2013--2017 年 Green Cross (China) Biotechnology Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin ( yuan / bottle) value (million) profit information table 129 in FIG 2013--2017 年 Green Cross Co. (China) Biotechnology Co., Ltd. intravenous human immunoglobulin (pH4) capacity production and growth rate 130 Table Guizhou Sino-Thai biotechnology Company Information Table (Products Design, product areas, origin, production, expansion plans, market position, contact information, etc. 13 items) 130 Table 2013--2017 Guizhou Biotechnology Co., Ltd. Thailand intravenous human immunoglobulin ( pH4) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million) profit information table 131 in FIG 2013--2017 Guizhou Biotechnology Co., Ltd. Thailand intravenous human immunoglobulin (pH4) Capacity Production ( (Product Design, product areas, origin, production, expansion plans, market position, contact information, etc. 13 items) million bottles) and growth rate 132 Table Lanzhou Institute of Biological Products Co., Ltd. Company Information Table 132 Figure Lanzhou Biological Products Institute LLC intravenous human immunoglobulin (pH4) 134 Table 2013--2017 Lanzhou Institute of Biological Products Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin (yuan / bottle ) value (million) profit information table 134 Figure 2013 - 2017 Limited Lanzhou Institute of Biological Products Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 135 Table Xi'an back to the days of blood products Ltd Company Information Table (Products Design, product areas, origin, production, expansion plans, market position, contact information, etc. 13 items) 135 Tu Xian back to the days of intravenous blood products limited liability company human immunoglobulin (pH4) 137 Table Xi'an back to the days of blood products limited liability company intravenous human immunoglobulin (pH4) Technical Data 137 Table 2013--2017 Xi'an back to the days of blood products limited liability company intravenous human immunoglobulin (pH4) Capacity Production (million bottles ) gross cost price (yuan / bottle) value (million) profit information table 138 in FIG 2013--2017 Xi'an back to the days of blood products limited liability company intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 138 Table Hunan violet Guhannanyue Pharmaceutical Co. Information Table (Products Design, product areas, origin, production, expansion plans, market position, contact information, etc. 13 items) 139 Figure Hunan Pharmaceutical Co., Ltd. Static purple Guhannanyue NOTE human immunoglobulin (pH4) 140 Table Hunan Pharmaceutical Co., Ltd. purple Guhannanyue intravenous human immunoglobulin (pH4) Technical Data 140 Table 2013--2017 Pharmaceutical Co., Ltd. in Hunan violet Guhannanyue intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million) profit information table 142 in FIG 2013--2017 Pharmaceutical Co., Ltd. in Hunan violet Guhannanyue intravenous human immunoglobulin (pH4) capacity Yield and growth rate 142 Table Zhejiang Hai Kang Biological Products Co., Ltd. Company Information Table (Products Design, product areas, origin, production, expansion plans, market position, contact information, etc. 13 items) 143 Figure Zhejiang Hai Kang Biological Products LLC intravenous human immunoglobulin (pH4) 145 Table Zhejiang Hai Kang Biological Products Co., Ltd. intravenous human immunoglobulin (pH4) Technical Data 145 Table 2013--2017 Zhejiang Hai Kang Biological Products Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin (yuan / bottle) value (million) profit information table 146 in FIG 2013--2017 Zhejiang Hai Kang Biological Products Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) and growth rate 146 Table Yunnan Watson Biotechnology Co., Ltd. Company Information Table (Products Design, product areas, origin, production, expansion plans, market position, contact information and other 13 items ) subsidiaries and products 147 Tu Wosen creature pharmaceutical field 148 Table 2013--2017 Yunnan Watson Biotechnology Co., Ltd. intravenous human immunoglobulin (pH4) Capacity Production (million bottles) cost price margin (yuan / bottle ) value (million) profit information table 148 in FIG 2013--2017 Yunnan Watson Biotechnology Co., Ltd. intravenous human immunoglobulin (pH4) capacity production and growth rate 149 Table 2012 China intravenous human immunoglobulin ( Progress in the implementation pH4) project SWOT List 150 Table 20 million bottles / year intravenous human immunoglobulin item list 152 Table 20 million bottles / year investment intravenous human immunoglobulin list of contents 152 Table 20 million bottles / year intravenous human immunoglobulin globulin (pH4) (Specifications: 2.5g) project feasibility analysis 152 List